Search Results 1-10 of 16602 for Pompe Disease
Alglucosidase alfa injection is an enzyme used to treat infantile-onset Pompe disease, which is also called glycogen storage disease type II. It contains a ...
Avalglucosidase alfa-ngpt injection is an enzyme used to treat late-onset of Pompe disease, which is also called glycogen storage disease type II. It ...
People with Pompe disease are not able to make enough of this enzyme. This medicine is to be given only by or under the direct supervision of your doctor ...
Legionnaires' disease is a severe form of pneumonia — lung inflammation usually caused by infection. It's caused by a bacterium known as legionella.
Caused by gene changes, these disorders affect the body's ability to change food into energy. They also affect how energy is used, such as for cell repair.
Miglustat is used in combination with cipaglucosidase alfa-atga injection (Pombiliti™) to treat late-onset of Pompe disease in patients who are not improving on ...
Whipple disease is a rare bacterial infection that most often affects your joints and digestive system. Whipple disease interferes with normal digestion by ...
This childhood condition occurs when blood supply to the ball part of the hip joint is interrupted for a short time, making the bone fracture easily and ...
Dosing · For Pompe disease: Adults weighing 50 kilograms (kg) or more—260 milligrams (mg) every other week. Adults weighing 40 to less than 50 kg—195 mg every ...
Infection from the polio virus once caused paralysis and death. However, the introduction of the inactivated polio vaccine in the 1950s greatly reduced polio's ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.